- Home
- VKTX vs KD Comparison
VKTX vs KD Comparison
Compare VKTX & KD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- KD
- Stock Information
- Founded
- VKTX 2012
- KD 2020
- Country
- VKTX United States
- KD United States
- Employees
- VKTX N/A
- KD N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- KD EDP Services
- Sector
- VKTX Health Care
- KD Technology
- Exchange
- VKTX Nasdaq
- KD Nasdaq
- Market Cap
- VKTX 4.6B
- KD 5.3B
- IPO Year
- VKTX 2015
- KD N/A
- Fundamental
- Price
- VKTX $42.25
- KD $34.53
- Analyst Decision
- VKTX Strong Buy
- KD Strong Buy
- Analyst Count
- VKTX 12
- KD 4
- Target Price
- VKTX $106.75
- KD $36.75
- AVG Volume (30 Days)
- VKTX 3.7M
- KD 2.1M
- Earning Date
- VKTX 02-05-2025
- KD 02-04-2025
- Dividend Yield
- VKTX N/A
- KD N/A
- EPS Growth
- VKTX N/A
- KD N/A
- EPS
- VKTX N/A
- KD N/A
- Revenue
- VKTX N/A
- KD $15,299,000,000.00
- Revenue This Year
- VKTX N/A
- KD N/A
- Revenue Next Year
- VKTX N/A
- KD $1.41
- P/E Ratio
- VKTX N/A
- KD N/A
- Revenue Growth
- VKTX N/A
- KD N/A
- 52 Week Low
- VKTX $17.23
- KD $19.19
- 52 Week High
- VKTX $99.41
- KD $36.43
- Technical
- Relative Strength Index (RSI)
- VKTX 33.93
- KD 62.99
- Support Level
- VKTX $37.80
- KD $33.91
- Resistance Level
- VKTX $48.55
- KD $35.94
- Average True Range (ATR)
- VKTX 2.54
- KD 0.91
- MACD
- VKTX -0.45
- KD -0.42
- Stochastic Oscillator
- VKTX 30.11
- KD 34.76
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About KD Kyndryl Holdings Inc.
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.